Neurogene Inc (NGNE)
40.67
+4.25
(+11.67%)
USD |
NASDAQ |
Jul 01, 16:00
40.59
-0.08
(-0.20%)
After-Hours: 20:00
Neurogene Total Liabilities (Quarterly): 24.57M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.57M |
| September 30, 2023 | 257.22M |
| Date | Value |
|---|---|
| June 30, 2023 | 254.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.57M
Minimum
Mar 2024
257.22M
Maximum
Sep 2023
178.88M
Average
254.85M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Taysha Gene Therapies Inc | 99.15M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.581M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 195.35M |
| Shareholders Equity (Quarterly) | 170.78M |